Page 204 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

194 ELECTROLYTE DISORDERS

metabolism in patients with chronic kidney disease. 631. Yanagawa N, Lee DBN. Renal handling of calcium and
Kidney Int 2003;63:1836–42. phosphorus. In: Coe FL, Favus MJ, editors. Disorders
618. Wisner ER, Nyland TG. Ultrasonography of the thyroid of bone and mineral metabolism. New York: Raven Press;
and parathyroid glands. Vet Clin North Am Small Anim 1992. p. 3–40.
Pract 1998;28:973–91. 632. Yang KH, dePapp AE, Soifer NE, et al. Parathyroid
619. Wisner ER, Penninck D, Biller DS, et al. High-resolution hormone-related protein: evidence for isoform- and
parathyroid sonography. Vet Radiol Ultrasound tissue-specific posttranslational processing. Biochemistry
1997;38:462–6. 1994;33:7460–9.
620. Wolf M. Active Vitamin D and survival. J Am Soc Nephrol 633. Yasuda T, Banville D, Rabbani SA, et al. Rat parathyroid
2008;19:1442–3. hormone-like peptide: comparison with the human
621. Wolf M, Thadhani R. Vitamin D in patients with renal fail- homologue and expression in malignant and normal tis-
ure: a summary of observational mortality studies and sue. Mol Endocrinol 1989;3:518–25.
steps moving forward. J Steroid Biochem and Mol Biol 634. Yu J, Papavasiliou V, Rhim J, et al. Vitamin D analogs: new
2007;103:487–90. therapeutic agents for the treatment of squamous cancer
622. Won DS, Park C, In YJ, et al. A case of nutritional second- and its associated hypercalcemia. Anticancer Drugs
ary hyperparathyroidism in a Siberian tiger cub. J Vet Med 1995;6:101–8.
Sci 2004;66:551–3. 635. Yudd M, Llach F. Current medical management of second-
623. Woo J, Cannon DC. Metabolic intermediates and inor- ary hyperparathyroidism. Am J Med Sci 2000;320:100–6.
ganic ions. In: 17th ed. Philadelphia: WB Saunders; 636. Zaloga GP, Chernow B. The multifactorial basis for hypo-
1984. p. 133–179. calcemia during sepsis: studies of the parathyroid hor-
624. Wooldridge JD, Gregory CR. Ionized and total serum mone-vitamin D axis. Ann Intern Med 1987;107:36–41.
magnesium concentrations in feline renal transplant 637. Zaloga GP, Malcolm D, Holaday J, et al. Verapamil
recipients. Vet Surg 1999;28:31–7. reverses calcium cardiotoxicity. Ann Emerg Med
625. Worth GK, Vasikaran SD, Retallack RW, et al. Major 1987;16:637–9.
method-specific differences in the measurement of 638. Zaloga GP, Willey S, Tomasic P, et al. Free fatty acids alter
intact parathyroid hormone: studies in patients with and calcium binding: a cause for misinterpretation of serum
without chronic renal failure. Ann Clin Biochem calcium values and hypocalcemia in critical illness. J Clin
2004;41:149–54. Endocrinol Metab 1987;64:1010–4.
626. Wright KN, Breitschwerdt EB, Feldman JM, et al. Diag- 639. Zawada Jr ET, Saelens DA, Lembke JM. Influence of cal-
nostic and therapeutic considerations in a hypercalcemic cium infusion on plasma atrial natriuretic peptide in con-
dog with multiple endocrine neoplasia. J Am Anim Hosp scious dogs: intervention with calcium antagonist,
Assoc 1995;31:156–62. verapamil. Miner Electrolyte Metab 1990;16:369–77.
627. Wu-Wong JR, Melnick J. Vascular calcification in chronic 640. Zelikovic I, Chesney RW. Vitamin D and mineral metab-
kidney failure: role of Vitamin D receptor. Curr Opin olism: the role of the kidney in health and disease. World
Investig Drugs 2007;8:237–47. Rev Nutr Diet 1989;59:156–216.
628. Wysolmerski JJ, Stewart AF, Martin JT. Physiological 641. Zini E, Hauser B, Ossent P, Dennler R, Glaus TM.
actions of PTH and PTHrP: epidermal, mammary, repro- Pansteatitis and severe hypocalcaemia in a cat. J Feline
ductive, and pancreatic tissues. In: Bilezikian JP, Med Surg 2006;9(2):168–71.
Marcus R, Levine MA, editors. The parathyroids. San 642. Zitterman A. Vitamin D in preventive medicine: are we
Diego: Academic Press; 2001. p. 275–292. ignoring the evidence? Br J Nutr 2003;89:552–72.
629. Wysolmerski JJ. The evolutionary origins of maternal cal- 643. Zittermann A, Schleithoff SS, Frisch S, et al. Circulating
cium and bone metabolism during lactation. J Mammary calcitriol concentrations and total mortality. Clin Chem
Gland Biol Neoplasia 2002;7:267–76. 2009;55:1163–70.
630. Yajima A, Pasch A, Nitta K. Efficacy and safety of 644. Zivin JR, Gooley T, Zager RA, et al. Hypocalcemia:
Cinacalcet in chronic kidney disease stage III and IV. Clin a pervasive metabolic abnormality in the critically ill.
Med Thera 2009;1:1661–6. Am J Kidney Dis 2001;37:689–98.